Philip Astley-sparke - Net Worth and Insider Trading
Philip Astley-sparke Net Worth
The estimated net worth of Philip Astley-sparke is at least $15 Million dollars as of 2025-01-19. Philip Astley-sparke is the Executive Chairman of Replimune Group Inc and owns about 1,487,350 shares of Replimune Group Inc (REPL) stock worth over $15 Million. Philip Astley-sparke is also the Director of uniQure NV and owns about 9,946 shares of uniQure NV (QURE) stock worth over $139,741. Details can be seen in Philip Astley-sparke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Philip Astley-sparke has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Philip Astley-sparke
Philip Astley-sparke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Philip Astley-sparke owns 3 companies in total, including Replimune Group Inc (REPL) , uniQure NV (QURE) , and Forbion European Acquisition Corp (FRBN) .
Click here to see the complete history of Philip Astley-sparke’s form 4 insider trades.
Insider Ownership Summary of Philip Astley-sparke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REPL | Replimune Group Inc | 2024-05-16 | director & 10 percent owner & Executive Chairman |
| QURE | uniQure NV | 2021-03-02 | director |
| FRBN | Forbion European Acquisition Corp | 2021-12-09 | director |
Philip Astley-sparke Latest Holdings Summary
Philip Astley-sparke currently owns a total of 2 stocks. Among these stocks, Philip Astley-sparke owns 1,487,350 shares of Replimune Group Inc (REPL) as of May 16, 2024, with a value of $15 Million and a weighting of 99.08%. Philip Astley-sparke also owns 9,946 shares of uniQure NV (QURE) as of March 2, 2021, with a value of $139,741 and a weighting of 0.92%.
Latest Holdings of Philip Astley-sparke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REPL | Replimune Group Inc | 2024-05-16 | 1,487,350 | 10.14 | 15,081,729 |
| QURE | uniQure NV | 2021-03-02 | 9,946 | 14.05 | 139,741 |
Holding Weightings of Philip Astley-sparke
Philip Astley-sparke Form 4 Trading Tracker
According to the SEC Form 4 filings, Philip Astley-sparke has made a total of 5 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Replimune Group Inc is the sale of 37,928 shares on May 16, 2024, which brought Philip Astley-sparke around $245,394.
According to the SEC Form 4 filings, Philip Astley-sparke has made a total of 2 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in uniQure NV is the sale of 504 shares on March 2, 2021, which brought Philip Astley-sparke around $18,950.
Insider Trading History of Philip Astley-sparke
- 1
Philip Astley-sparke Trading Performance
Philip Astley-sparke Ownership Network
Ownership Network List of Philip Astley-sparke
Ownership Network Relation of Philip Astley-sparke
Philip Astley-sparke Owned Company Details
What does Replimune Group Inc do?
Who are the key executives at Replimune Group Inc?
Philip Astley-sparke is the director & 10 percent owner & Executive Chairman of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Commercial Officer Sushil Patel , Chief Commercial Officer Christopher Sarchi , and Chief Medical Officer Konstantinos Xynos .
Replimune Group Inc (REPL) Insider Trades Summary
Over the past 18 months, Philip Astley-sparke made 1 insider transaction in Replimune Group Inc (REPL) with a net sale of 37,928. Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 36,807 shares made by Konstantinos Xynos , a net sale of 25,658 shares made by Pamela Esposito , and a net sale of 12,680 shares made by Christopher Sarchi .
In summary, during the past 3 months, insiders sold 22,453 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 22,453 shares. During the past 18 months, 183,582 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 183,582 shares.
Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Replimune Group Inc Insider Transactions
Philip Astley-sparke Mailing Address
Above is the net worth, insider trading, and ownership report for Philip Astley-sparke. You might contact Philip Astley-sparke via mailing address: C/o Biovex Group, Inc., 34 Commerce Way, Woburn Ma 10801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
